Feedback

The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model

Affiliation
Laboratory of Chinese Medicine Preparation ,Shandong Research Academy of Traditional Chinese Medicine ,Jinan ,China
Xu, Nan;
Affiliation
The Faculty of Medicine ,Qilu Institute of Technology ,Jinan ,China
Ijaz, Muhammad;
Affiliation
Shandong Medicine and Health Key Laboratory of Clinical Pharmacy ,Department of Clinical Pharmacy ,The First Affiliated Hospital of Shandong First Medical University ,Shandong Provincial Qianfoshan Hospital ,Shandong Engineering and Technology Research Center for Pediatric Drug Development ,Jinan ,China
Shu, Yishuo;
Affiliation
Shandong Medicine and Health Key Laboratory of Clinical Pharmacy ,Department of Clinical Pharmacy ,The First Affiliated Hospital of Shandong First Medical University ,Shandong Provincial Qianfoshan Hospital ,Shandong Engineering and Technology Research Center for Pediatric Drug Development ,Jinan ,China
Wang, Peng;
Affiliation
Laboratory of Chinese Medicine Preparation ,Shandong Research Academy of Traditional Chinese Medicine ,Jinan ,China
Ma, Lei;
Affiliation
Laboratory of Chinese Medicine Preparation ,Shandong Research Academy of Traditional Chinese Medicine ,Jinan ,China
Wang, Ping;
Affiliation
The Faculty of Medicine ,Qilu Institute of Technology ,Jinan ,China
Ding, Hailing;
Affiliation
Laboratory of Chinese Medicine Preparation ,Shandong Research Academy of Traditional Chinese Medicine ,Jinan ,China
Shahbaz, Muhammad;
Affiliation
The Faculty of Medicine ,Qilu Institute of Technology ,Jinan ,China
Shi, Haiyan

Background: Wendan Decoction (WDD) is a six-herb Chinese medicine recipe that was first mentioned in about 652 AD. It is frequently used to treat hyperlipidemic patients’ clinical complaints. According to reports, oxidative stress has a significant role in hyperlipidemia. Purpose: There has not yet been a thorough pharmacokinetic-pharmacodynamic (PK-PD) examination of the clinical efficacy of WDD in the context of hyperlipemia-related oxidative stress. Therefore, the goal of this research is to explore the antioxidant essence of WDD by developing a PK-PD model, ordering to assure its implication in treating hyperlipidemia in medical practice. Methods: The model rats of foodborne hyperlipidemia were established by feeding with high-fat feed, and the lipid-lowering effect of WDD was explored. The plasma drug concentration of rats at different doses were measured by UPL-MS/MS technology, and PK parameters were calculated using Phoenix WinNonlin 8.1 software. The level of lipid peroxide (LPO) in plasma at different time points was measured by enzyme labeling instrument. Finally, the PK-PD model was established by using Phoenix WinNonlin 8.1 software, to explore the lipid-lowering effect of WDD and the relation between the dynamic changes of chemical components and antioxidant effect. Results: The findings suggested that, WDD can reduce the levels of triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) in plasma, and high-density lipoprotein cholesterol (HDL-C) was related to the dosage. Between the peak drug levels and the WDD’s maximal therapeutic response, there existed a hysteresis. WDD’s effect-concentration curves displayed a counterclockwise delaying loop. Alternatively, among the ten components of WDD, hesperetin, quercetin, naringenin and tangeretin might exert more significant effects in regulating the LPO levels in hyperlipidemic rats. Conclusion: This study can be helpful for other investigators to study the lipid-lowering effect of WDD.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2024 Xu, Ijaz, Shu, Wang, Ma, Wang, Ding, Shahbaz and Shi.

Use and reproduction: